Because we encountered p53-pathway restoring compounds that did not activate p73 and p63 or that did not lead to mutant p53 downregulation in mutant p53-expressing tumor cell lines, we extended our search for other transcription factors beyond p53 family members. The gene discussed is TP53; the disease is neoplasm.